Dark

Check out our API

ATHX
ATHERSYS INC NEW
stock OTC

Inactive

Jan 8, 2024

0.0135USD-33.498%(-0.0068)6,462,682

Pre-market

0.00USD-100.000%(-0.02)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 21, 2022

05:23AM EST Athersys Names Daniel Cmardo CEO Benzinga

Nov 30, 2021

04:42PM EST Athersys Highlights Publication Of Data From MUST-ARDS Trial In Intensive Care Medicine' Benzinga

Nov 19, 2021

10:09AM EST Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021 Benzinga

08:24AM EST B of A Securities Downgrades Athersys to Neutral, Announces $1.25 Price Target Benzinga

Nov 15, 2021

05:08PM EST Athersys Q3 EPS $(0.07) Beats $(0.11) Estimate, Sales $4.79M Beat $60.00K Estimate Benzinga

11:07AM EST Earnings Scheduled For November 15, 2021 Benzinga

10:37AM EST The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More Benzinga

Nov 12, 2021

07:47AM EST The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares Benzinga

Oct 6, 2021

07:33AM EDT The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal Benzinga

Oct 1, 2021

07:56AM EDT The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO Benzinga

Sep 30, 2021

07:43AM EDT The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug Benzinga

Sep 28, 2021

07:20AM EDT Athersys To Present At 2021 Cell & Gene Meeting On The Mesa Hybrid Conference Oct. 12-14 Benzinga

Aug 10, 2021

09:17AM EDT Athersys Reports Its Partner, HEALIOS KK, Completes Enrollment In TREASURE Study Of MultiStem Treatment For Ischemic Stroke Benzinga

Aug 9, 2021

05:11PM EDT Athersys: Q2 Earnings Insights Benzinga

05:07PM EDT Athersys Q2 EPS $(0.10), Inline Benzinga

11:07AM EDT The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight Benzinga

04:11AM EDT Earnings Scheduled For August 9, 2021 Benzinga

Aug 8, 2021

10:11AM EDT The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight Benzinga

Aug 6, 2021

07:42AM EDT The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO Benzinga

Aug 5, 2021

06:21PM EDT Athersys and HEALIOS K.K. Announce Advancement of Their MultiStem Commercial Partnership Benzinga

Jul 29, 2021

03:02PM EDT Longeveron's Novel Therapy Looks to Tackle COVID-19, Flu-Related ARDS Benzinga

Jul 20, 2021

08:20AM EDT The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street Benzinga

Jul 16, 2021

07:37AM EDT The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study Benzinga

Jul 1, 2021

08:07AM EDT The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts Benzinga

Jun 30, 2021

06:04AM EDT Athersys Highlights Data Published In Scientific Reports Journal Involving MultiStem Benzinga

May 12, 2021

08:57AM EDT The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron Benzinga

May 11, 2021

07:54AM EDT The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings Benzinga

May 7, 2021

07:40AM EDT The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs Benzinga

May 6, 2021

04:26PM EDT Athersys Q1 EPS $(0.13) Misses $(0.09) Estimate Benzinga

07:49AM EDT The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom Benzinga

04:17AM EDT Earnings Scheduled For May 6, 2021 Benzinga

Apr 28, 2021

01:01PM EDT Athersys To Present At Bank of America Virtual Healthcare Conference On May 12 Benzinga

Mar 31, 2021

06:10AM EDT Athersys Reports That Its Partner, Healios Has Completed Enrollment In ONE-BRIDGE Study Of MultiStem For Acute Respiratory Distress Syndrome In Japan Benzinga

Mar 26, 2021

07:28AM EDT The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs Benzinga

Mar 25, 2021

04:10PM EDT Athersys Q4 EPS $(0.11), Inline, Sales $1.27M Up From $287.00K YoY Benzinga

07:58AM EDT The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut Benzinga

04:03AM EDT Earnings Scheduled For March 25, 2021 Benzinga

Feb 16, 2021

07:52AM EST Athersys Announces Cooperation Agreement With HEALIOS K.K. To 'reaffirm the mutual commitment to collaborative development of MultiStem in Japan'; Dr. Kagimoto To Dismiss Section 220 Litigation Benzinga

07:33AM EST Athersys Announces Gil Van Bokkelen to Step Down as Chairman and CEO; B.J. Lehmann Appointed Interim CEO Benzinga

Dec 21, 2020

06:03AM EST UTHealth in Houston and Athersys Announce Commencement of Patient Enrollment in a Phase 2 Trial Evaluating MultiStem Cell Therapy in Trauma Benzinga

Nov 30, 2020

09:26AM EST Athersys Reports In 13D Filing That Healios KK Says On Nov 30., CEO Hardy TS Kagimoto Sent Letter To Other Members Of Athersys Board, Says Urges The Full Co Board To Take A More Proactive Approach In Overseeing Management Benzinga

Nov 18, 2020

09:56AM EST Hardy TS Kagimoto Says Objects To The Process That Lead To Athersys Board's Recent Appointment Of Three New Directors Benzinga

09:51AM EST Healios K.K. Reports In 13D Filing An 8.3% Stake In Athersys Benzinga

Nov 13, 2020

09:35AM EST Hardy TS Kagimoto Says Believes Athersus Has Need To Improve Operational Execution; Says Expressed Views To Co's Board, Management Benzinga

Nov 9, 2020

04:43PM EST Athersys Q3 EPS $(0.11) Misses $(0.09) Estimate, Sales $86.00K Miss $170.00K Estimate Benzinga

04:13AM EST Earnings Scheduled For November 9, 2020 Benzinga

Nov 8, 2020

03:58PM EST The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions Benzinga

12:47PM EST The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs Benzinga

Sep 28, 2020

11:19AM EDT 'Important research published in Stem Cell Translational Medicine by our collaborators at Maastricht UMC+ using #Athersys' #MultiStem cell therapy in a fetal sheep model suggest the cells protect the cerebellum after asphyxia' -Tweet By Co. Benzinga

Sep 23, 2020

09:57AM EDT Return On Capital Employed Overview: Athersys Benzinga

06:01AM EDT Athersys Announces FDA Has Granted RMAT Designation To MultiStem Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome Benzinga

Sep 8, 2020

01:56PM EDT Athersys Shares Move Higher; Traders Circulate Paper Titled 'Multipotent adult progenitor cells grown under xenobiotic-free conditions support vascularization during wound healing' Benzinga

Aug 10, 2020

04:03PM EDT Athersys Q2 EPS $(0.10) Misses $(0.08) Estimate, Sales $84.00K Down From $4.26M YoY Benzinga

04:10AM EDT Earnings Scheduled For August 10, 2020 Benzinga

Share